封面
市場調查報告書
商品編碼
1768087

醫療保健合約研究外包市場按服務類型、最終用戶和地區分類

Healthcare Contract Research Outsourcing Market, By Services Type, By End User (CROs, Clinical Trial Laboratories, and AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

醫療保健合約研究外包市場規模預計在 2025 年達到 1,726.3 億美元,預計到 2032 年將達到 4,620 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 15.1%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 1726.3億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 15.10% 2032年價值預測 4620億美元

醫療保健合約研究外包由製藥和醫療設備產業承擔,用於開發新藥和醫療設備。臨床試驗是藥物和醫療設備開發的重要組成部分,目前,臨床試驗在不同地區的多個地點進行。藥物開發成本和時間的不斷成長預計將在預測期內推動全球醫療保健委託市場的成長。此外,關鍵藥物專利到期數量的增加也有望推動市場成長。

市場動態

日益增多的合作與夥伴關係正在促進全球醫療研究外包市場的成長。例如,2022年9月,提供全球端到端開發服務的醫療設備合約研發組織 (CRO) 北美科學協會 (NAMSA) 與 CGuard 栓塞預防系統 (EPS) 的開發商 InspireMD, Inc. 達成外包夥伴關係夥伴關係,以加速醫療設備的開發和商業化。 CGuard 栓塞預防系統用於治療頸動脈疾病和預防中風。

本研究的主要特點

  • 本報告對全球醫療保健合約研究外包市場進行了詳細分析,並以 2024 年為基準年,展示了預測期 2025 年至 2032 年的市場規模(十億美元)和復合年成長率。
  • 它還強調了各個領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球醫療保健合約研究外包市場的主要企業已根據公司概況、業務績效、產品系列、市場影響、分銷策略、關鍵發展、策略和未來計劃等參數進行了分析。
  • 研究中涉及的關鍵公司包括 IQVIA Inc.、Covance Inc.(Labcorp 的子公司)、Pharmaceutical Product Development Inc.(Thermo Fisher Scientific 的子公司)、Parexel International (MA) Corporation、Charles River Laboratories、ICON plc、Medidata、Inventiv Health, Inc.(Syneos Ltd. 的子公司)。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術改進、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 可以透過用於分析全球醫療合約研究外包市場的各種策略矩陣來促進相關人員的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 市場機會
  • 影響分析
  • 最新產品發布
  • 流行病學
  • 合併、收購和合作
  • 監管情景
  • 主要進展
  • PEST分析

4. 全球醫療保健合約研究外包市場(依服務類型),2020 年至 2032 年

  • 臨床試驗
  • 監管服務
  • 醫學寫作
  • 臨床數據管理
  • 其他

5. 全球醫療保健合約研究外包市場(按最終用戶分類),2020 年至 2032 年

  • CRO
  • 臨床試驗實驗室
  • AMC

6. 全球醫療保健合約研究外包市場(按地區分類),2020 年至 2032 年

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第7章 競爭態勢

  • IQVIA Inc.
  • Covance Inc(A subsidiary of Labcorp)
  • Pharmaceutical Product Development Inc(A subsidiary of Thermo Fisher Scientific Inc.)
  • Parexel International(MA)Corporation
  • Charles River Laboratories
  • ICON plc
  • Medidata
  • Inventiv Health, Inc.(A subsidiary of Syneos Health)
  • Medpace
  • Piramal Enterprises Ltd.

第 8 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI3788

Healthcare Contract Research Outsourcing Market is estimated to be valued at USD 172.63 Bn in 2025 and is expected to reach USD 462.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 172.63 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.10% 2032 Value Projection: USD 462.00 Bn

Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current scenario, clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development are expected to propel the global healthcare contract research outsourcing market growth over the forecast period. Furthermore, the increasing number of patent expirations of leading drugs is also expected to aid in the growth of the market.

Market Dynamics

Increasing incidences of collaborations and partnerships are attributed to the growth of the global healthcare contract research outsourcing market. For instance, in September 2022, North American Science Associates, LLC (NAMSA), a Medical Devices Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc., a developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease and prevention of strokes, entered an outsourcing partnership to accelerate medical device development and commercialization.

Key features of the study

  • This report provides an in-depth analysis of the global healthcare contract research outsourcing market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global healthcare contract research outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • The key companies covered as a part of this study include, IQVIA Inc., Covance Inc (a subsidiary of Labcorp), Pharmaceutical Product Development Inc (a subsidiary of Thermo Fisher Scientific Inc), Parexel International (MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. (A subsidiary of Syneos Health), Medpace, and Piramal Enterprises Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global healthcare contract research outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare contract research outsourcing market.

Market Segmentation

  • Global Healthcare Contract Research Outsourcing Market, By Services Type
    • Clinical Trials
    • Regulatory Services
    • Medical Writing
    • Clinical Data Management
    • Others
  • Global Healthcare Contract Research Outsourcing Market, By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
  • Global Healthcare Contract Research Outsourcing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • IQVIA Inc.
    • Covance Inc (A subsidiary of Labcorp)
    • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Parexel International (MA) Corporation
    • Charles River Laboratories
    • ICON plc
    • Medidata
    • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Medpace
    • Piramal Enterprises Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Healthcare Contract Research Outsourcing Market, By Service Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Clinical Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
      • Drug Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
  • Regulatory Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Medical Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Data Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

5. Global Healthcare Contract Research Outsourcing Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • CROs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Trial Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • AMCs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

6. Global Healthcare Contract Research Outsourcing Market, By Region, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • IQVIA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance Inc (A subsidiary of Labcorp)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Parexel International (MA) Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ICON plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medidata
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medpace
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Piramal Enterprises Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us